Tag: intracept
Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
Relievant announces publication of Level I SMART study data
Relievant Medsystems has announced the publication of long-term data from the Level I SMART trial showing durability of improvements in pain and function beyond...
SMART trial shows nerve ablation “well-tolerated and effective”
Both surgical and conservative methods of treating chronic low back pain have reported variable scientific and clinical outcomes. New prospective, double-blinded, randomised, sham-controlled trial...